Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Cholesterol Ester Storage Disease

1-anilino-8-naphthalenesulfonate has been researched along with Cholesterol Ester Storage Disease in 36 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Cholesterol Ester Storage Disease: An autosomal recessive disorder caused by mutations in the gene for acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes.

Research Excerpts

ExcerptRelevanceReference
"We confirmed accumulation of glycogen and lipids, particularly cholesterol esters, in the liver of a patient with cholesterol ester storage disease (CESD)."3.70Accumulated lipids, aberrant fatty acid composition and defective cholesterol ester hydrolase activity in cholesterol ester storage disease. ( Imai, K; Matsumoto, K; Okuyama, T; Shimizu, M; Tashiro, Y; Todoroki, T; Watanabe, K, 2000)
"The fatal infantile phenotype (Wolman's disease) with generalized storage of both types of apolar lipids."1.30[Lysosomal acid lipase deficiency. Overview of Czech patients]. ( Chlumská, A; Elleder, M; Hyánek, J; Ledvinová, J; Lohse, P; Poupĕtová, H; Stozický, F; Sýkora, J; Zeman, J, 1999)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.56)18.7374
1990's23 (63.89)18.2507
2000's7 (19.44)29.6817
2010's3 (8.33)24.3611
2020's1 (2.78)2.80

Authors

AuthorsStudies
Tebani, A1
Sudrié-Arnaud, B1
Boudabous, H1
Brassier, A1
Anty, R1
Snanoudj, S1
Abergel, A1
Abi Warde, MT1
Bardou-Jacquet, E1
Belbouab, R1
Blanchet, E1
Borderon, C1
Bronowicki, JP1
Cariou, B1
Carette, C1
Dabbas, M1
Dranguet, H1
de Ledinghen, V1
Ferrières, J1
Guillaume, M1
Krempf, M1
Lacaille, F1
Larrey, D1
Leroy, V1
Musikas, M1
Nguyen-Khac, E1
Ouzan, D1
Perarnau, JM1
Pilon, C1
Ratzlu, V1
Thebaut, A1
Thevenot, T1
Tragin, I1
Triolo, V1
Vergès, B1
Vergnaud, S1
Bekri, S1
Civallero, G1
De Mari, J1
Bittar, C1
Burin, M1
Giugliani, R1
Tylki-Szymańska, A1
Jurecka, A1
Burton, BK1
Deegan, PB1
Enns, GM1
Guardamagna, O1
Horslen, S1
Hovingh, GK1
Lobritto, SJ1
Malinova, V1
McLin, VA1
Raiman, J1
Di Rocco, M1
Santra, S1
Sharma, R1
Sykut-Cegielska, J1
Whitley, CB1
Eckert, S1
Valayannopoulos, V1
Quinn, AG1
Boldrini, R1
Devito, R1
Biselli, R1
Filocamo, M1
Bosman, C1
Du, H6
Levine, M2
Ganesa, C1
Witte, DP3
Cole, ES1
Grabowski, GA6
Ameis, D3
Brockmann, G1
Knoblich, R1
Merkel, M1
Ostlund, RE1
Yang, JW1
Coates, PM1
Cortner, JA1
Feinman, SV1
Greten, H3
Muntoni, S3
Wiebusch, H3
Funke, H3
Ros, E1
Seedorf, U3
Assmann, G3
Christensen, NC1
Skovby, F1
Nickel, V1
Roskos, M1
Ose, L1
Pagani, F3
Zagato, L1
Merati, G1
Paone, G2
Gridelli, B2
Maier, JA1
Klima, H2
Ullrich, K1
Aslanidis, C5
Fehringer, P3
Lackner, KJ1
Schmitz, G5
Tanaka, A3
Ries, S2
Büchler, C2
Becker, A1
Garcia, R2
Pariyarath, R2
Stuani, C2
Baralle, FE2
Lu, F1
Oberle, S1
Schwarzer, U1
Gasche, C2
Kain, R1
Exner, M1
Helbich, T1
Dejaco, C1
Ferenci, P1
Redonnet-Vernhet, I2
Chatelut, M2
Basile, JP1
Salvayre, R2
Levade, T2
Schindler, G1
Jung, N1
Schambach, A1
Vanier, MT1
Belli, DC1
Burlina, AB1
Ruotolo, G1
Rabusin, M1
Duanmu, M2
Witte, D1
Sheriff, S1
Bezerra, J1
Leonova, T1
vom Dahl, S1
Harzer, K1
Rolfs, A1
Albrecht, B1
Niederau, C1
Vogt, C1
van Weely, S1
Aerts, J1
Müller, G1
Häussinger, D1
Anderson, RA1
Bryson, GM1
Parks, JS1
Elleder, M2
Chlumska, A2
Ledvinová, J2
Poupetová, H2
Todoroki, T1
Matsumoto, K1
Watanabe, K1
Tashiro, Y1
Shimizu, M1
Okuyama, T1
Imai, K1
Hyánek, J1
Zeman, J1
Sýkora, J1
Stozický, F1
Lohse, P1
Heur, M2
Hui, DY1
Mishra, J2
Schiavi, S1
Nègre, A1
Dagan, A1
Gatt, S1
Piskorska, D1
Kopieczna-Grzebieniak, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype[NCT01528917]49 participants (Actual)Observational2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

7 reviews available for 1-anilino-8-naphthalenesulfonate and Cholesterol Ester Storage Disease

ArticleYear
Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2014, Volume: 35, Issue:1

    Topics: Cholesterol Ester Storage Disease; Cholesterol Esters; Humans; Lipase; Liver Function Tests; Wolman

2014
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
    Nihon rinsho. Japanese journal of clinical medicine, 1995, Volume: 53, Issue:12

    Topics: Cholesterol Ester Storage Disease; Cholesterol Esters; Humans; Infant; Lipase; Lysosomes; Mutation;

1995
ACAT/CEH and ACEH/LAL: two key enzymes in hepatic cellular cholesterol homeostasis and their involvement in genetic disorders.
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34 Suppl 3

    Topics: Arteriosclerosis; Cholesterol; Cholesterol Ester Storage Disease; DNA Mutational Analysis; Humans; L

1996
[Acid lipase deficiency (Wolman disease and cholesteryl ester storage disease: CESD)].
    Ryoikibetsu shokogun shirizu, 1998, Issue:19 Pt 2

    Topics: Cholesterol Ester Storage Disease; Cholesterol Esters; Diagnosis, Differential; Humans; Lipase; Lyso

1998
Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.
    Molecular genetics and metabolism, 1998, Volume: 64, Issue:2

    Topics: Animals; Baculoviridae; Cell Line; Cells, Cultured; Child; Child, Preschool; Cholesterol Ester Stora

1998
[Wolman disease and cholesteryl ester storage disease].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Animals; Cholesterol Ester Storage Disease; Cholesterol Esters; Diagnosis, Differential; Humans; Lip

2001
[The role and mechanism of lysosomal acid lipase activity].
    Przeglad lekarski, 1988, Volume: 45, Issue:8

    Topics: Cholesterol Ester Storage Disease; Cholesterol Esters; Humans; Lipase; Lipoproteins, LDL; Lysosomes;

1988

Other Studies

29 other studies available for 1-anilino-8-naphthalenesulfonate and Cholesterol Ester Storage Disease

ArticleYear
Large-scale screening of lipase acid deficiency in at risk population.
    Clinica chimica acta; international journal of clinical chemistry, 2021, Volume: 519

    Topics: Cholesterol Ester Storage Disease; Cholesterol Esters; Female; Humans; Infant, Newborn; Lipase; Preg

2021
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
    Gene, 2014, Apr-10, Volume: 539, Issue:1

    Topics: Carbamates; Cells, Cultured; Cholesterol Ester Storage Disease; Dried Blood Spot Testing; Fibroblast

2014
Clinical Features of Lysosomal Acid Lipase Deficiency.
    Journal of pediatric gastroenterology and nutrition, 2015, Volume: 61, Issue:6

    Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Child; Child, Preschool; Chole

2015
Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy.
    Pathology, research and practice, 2004, Volume: 200, Issue:3

    Topics: Biopsy; Cells, Cultured; Child; Child, Preschool; Cholesterol Ester Storage Disease; Cholesterol Est

2004
The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.
    American journal of human genetics, 2005, Volume: 77, Issue:6

    Topics: Animals; Cells, Cultured; CHO Cells; Cholesterol Ester Storage Disease; Cholesterol Esters; Cricetin

2005
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease.
    Journal of lipid research, 1995, Volume: 36, Issue:2

    Topics: Adult; Alleles; Base Sequence; Cholesterol Ester Storage Disease; DNA Primers; Gene Deletion; Humans

1995
Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).
    Human genetics, 1995, Volume: 95, Issue:5

    Topics: Adult; Aged; Alleles; Base Sequence; beta-Galactosidase; Cholesterol Ester Storage Disease; Codon; D

1995
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:6

    Topics: Adult; Alleles; Amino Acid Sequence; Base Sequence; beta-Galactosidase; Cholesterol; Cholesterol Est

1995
A histidine to tyrosine replacement in lysosomal acid lipase causes cholesteryl ester storage disease.
    Human molecular genetics, 1994, Volume: 3, Issue:9

    Topics: Adolescent; Aged; Aged, 80 and over; Base Sequence; Cholesterol Ester Storage Disease; Consanguinity

1994
A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:6

    Topics: Adolescent; Adult; Amino Acid Sequence; Base Sequence; Child; Child, Preschool; Cholesterol Ester St

1993
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Genomics, 1996, Apr-01, Volume: 33, Issue:1

    Topics: Alternative Splicing; Amino Acid Sequence; Base Sequence; Cholesterol Ester Storage Disease; DNA Mut

1996
Tissue and cellular specific expression of murine lysosomal acid lipase mRNA and protein.
    Journal of lipid research, 1996, Volume: 37, Issue:5

    Topics: Amino Acid Sequence; Animals; Base Sequence; Cholesterol Ester Storage Disease; DNA, Complementary;

1996
Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease.
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34 Suppl 3

    Topics: Cholesterol Ester Storage Disease; DNA Mutational Analysis; DNA, Complementary; Genotype; Humans; Li

1996
Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.
    Human molecular genetics, 1996, Volume: 5, Issue:10

    Topics: Child; Child, Preschool; Cholesterol Ester Storage Disease; HeLa Cells; Heterozygote; Humans; Lipase

1996
A novel missense mutation (Gly2Arg) in the human lysosomal acid lipase gene is found in individuals with and without cholesterol ester storage disease (CESD).
    Clinical genetics, 1996, Volume: 50, Issue:2

    Topics: Alleles; Cholesterol Ester Storage Disease; Female; Gene Frequency; Germany; Humans; Lipase; Male; P

1996
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin.
    Journal of hepatology, 1997, Volume: 27, Issue:4

    Topics: Anticholesteremic Agents; Cholesterol Ester Storage Disease; Female; Genetic Variation; Humans; Imag

1997
Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase.
    Biochemical and molecular medicine, 1997, Volume: 62, Issue:1

    Topics: Adult; Cells, Cultured; Cholesterol Ester Storage Disease; Female; Humans; Lipase; Lysosomes; Male;

1997
A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease.
    Human mutation, 1998, Volume: 11, Issue:4

    Topics: Adult; Cholesterol Ester Storage Disease; Exons; Heterozygote; Humans; Lipase; Lysosomes; Male; Midd

1998
Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.
    Human mutation, 1998, Volume: 12, Issue:1

    Topics: Amino Acid Substitution; Animals; Base Sequence; Cells, Cultured; Cholesterol Ester Storage Disease;

1998
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
    Journal of lipid research, 1998, Volume: 39, Issue:7

    Topics: Amino Acid Substitution; Base Sequence; Child; Cholesterol Ester Storage Disease; Exons; Female; Gen

1998
Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.
    Human molecular genetics, 1998, Volume: 7, Issue:9

    Topics: Animals; Base Sequence; Cholesterol Ester Storage Disease; Disease Models, Animal; DNA Primers; Fema

1998
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation.
    Journal of hepatology, 1999, Volume: 31, Issue:4

    Topics: Adult; Anemia; Cholesterol Ester Storage Disease; Diagnosis, Differential; DNA, Recombinant; Exons;

1999
Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
    Molecular genetics and metabolism, 1999, Volume: 68, Issue:3

    Topics: Adult; Amino Acid Substitution; Animals; Base Sequence; Cells, Cultured; Child; Cholesterol Ester St

1999
Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma.
    Virchows Archiv : an international journal of pathology, 2000, Volume: 436, Issue:1

    Topics: Adult; Arteriosclerosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Choleste

2000
Accumulated lipids, aberrant fatty acid composition and defective cholesterol ester hydrolase activity in cholesterol ester storage disease.
    Annals of clinical biochemistry, 2000, Volume: 37 ( Pt 2)

    Topics: Child, Preschool; Cholesterol Ester Storage Disease; Cholesterol Esters; Fatty Acids; Glycogen; Huma

2000
[Lysosomal acid lipase deficiency. Overview of Czech patients].
    Casopis lekaru ceskych, 1999, Nov-29, Volume: 138, Issue:23

    Topics: Adult; Cholesterol Ester Storage Disease; Czech Republic; Female; Humans; Infant; Lipase; Lysosomes;

1999
Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span.
    Journal of lipid research, 2001, Volume: 42, Issue:4

    Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Aging; Animals; Blood Glucose; Cell Differentiati

2001
Enzyme therapy for lysosomal acid lipase deficiency in the mouse.
    Human molecular genetics, 2001, Aug-01, Volume: 10, Issue:16

    Topics: Animals; Antibodies; Cells, Cultured; Cholesterol Ester Storage Disease; Disease Models, Animal; Dru

2001
Pyrene-methyl lauryl ester, a new fluorescent substrate for lipases: use for diagnosis of acid lipase deficiency in Wolman's and cholesteryl ester storage diseases.
    Enzyme, 1989, Volume: 42, Issue:2

    Topics: Cell Line; Cells, Cultured; Cholesterol Ester Storage Disease; Clinical Enzyme Tests; Fluorescent Dy

1989